Misregulation of hepcidin is associated with disease (hemochromatosis, when iron-regulation of hepcidin is blunted, and anemia, when hepcidin is induced by inflammatory pathways or by genetic inactivation of its inhibitor TMPRSS6) (Sebastiani and Pantopoulos, 2011). This evidence concerns the gene HAMP and anemia (phenotype).